R&D
Molecular Glue Platform
SCROLL DOWN
Molecular
Glue Platform
PROTIER Biotech’s innovative molecular glue discovery platform is built on Rationale Design, a rational molecular design approach, enabling the rapid and efficient development of novel molecular glue therapeutics.
Key Features
Targeted Protein Degradation
Induces targeted protein–protein binding to degrade disease-causing proteins, delivering a fundamental degradation mechanism beyond simple inhibition.
.png)
Superior Drug Properties Compared to PROTAC
Optimized physicochemical properties for oral administration, ensuring cell membrane and BBB permeability along with high absorption.
.png)
Low Molecular Weight
Ensures development efficiency and stability from a CMC (Chemistry, Manufacturing, and Controls) perspective.
.png)
Broad Applicability
Expandable across multiple therapeutic areas, including oncology and inflammatory diseases.
.png)
Access to
Undruggable Targets
Expands the therapeutic scope to target proteins previously unreachable with conventional small-molecule therapies.
PROTIER-Glue Platform for Rational Design
